Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712836 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Prime Therapeutics Business Intelligence Report' returned 28 results - Page 1 of 2

  Sort by   
  Sorted by Rank Top-Bottom

FivePrime Therapeutics-Detailed Product Pipeline  
Life Science Analytics, March 2011, Pages: 27
FivePrime Therapeutics-Detailed Product Pipeline provides up to date insight into company’s business description, product information, pipeline details including both summary information


Korea Prime Pharm Co., Ltd.-Therapeutic Competitors Report  
Life Science Analytics, March 2011, Pages: 357
Korea Prime Pharm Co., Ltd.-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all


FivePrime Therapeutics, Inc.-Detailed Product Pipeline  
Life Science Analytics, July 2010, Pages: 28
FivePrime Therapeutics, Inc.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances


FivePrime Therapeutics-Therapeutic Competitors Report  
Life Science Analytics, March 2011, Pages: 134
FivePrime Therapeutics-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company


NeoCardiogenesis- Celebrating The Birth Of Regenerative Cardiology  
MRI Limited (Meta Reports), Nov 2008, Pages: 312
a “regenerative cardiology market analysis and business intelligence report”, the technology leaning of our research team in serendipity, discovered a breakthrough that has the potential to not only revitalize


Pfizer: Pipeline, Products, Performance, Potential  
Espicom Business Intelligence Ltd, Nov 2010, Pages: 228
Therapeutics Coley Pharmaceutical Group Inc Cytos Biotechnology AG Eisai Elusys Therapeutics Ensemble Discovery Five Prime Therapeutics Inc Flamel Technologies Inc Genentech Inc GlaxoSmithKline Graceway


ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due to Anti-Bacterial Resistance  
GBI Research, Jan 2012, Pages: 165
GBI Research, the leading business intelligence provider, has released its latest research, “ENT Disorders Market to 2017- Cephalosporins, Quinolones and Macrolides to Replace Older Therapies Due


Boehringer Ingelheim: Performance, Products, Pipeline and Potential  
Espicom Business Intelligence Ltd, Sep 2009, Pages: 120
Pharmaceutical company intelligence reports provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth


The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking  
GBI Research, Dec 2009, Pages: 69
GBI Research, the leading business intelligence provider, has released its latest research, “The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape


European Hospital Financing Reform - Developments and Business Implications for the Medical Device Industry  
HBS Consulting, June 2006, Pages: 113
reform in general develops in Europe. The current HBS Consulting report on European Hospital Financing Reform - Developments and Business Implications strives to provide a detailed overview


Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly  
GBI Research, Oct 2011, Pages: 103
Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly


Belarus Pharmaceuticals and Healthcare Report Q3 2010  
Business Monitor International, July 2010, Pages: 66
Business Monitor International's Belarus Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government


Lithuania Pharmaceuticals and Healthcare Report Q2 2010  
Business Monitor International, April 2010, Pages: 69
and Healthcare Business Environment Ratings for Emerging Europe, with only smaller Commonwealth of Independent States (CIS) markets deemed less attractive to multinational companies. The prime consideration


Malaysia Pharmaceuticals and Healthcare Report Q2 2011  
Business Monitor International, March 2011, Pages: 112
Business Monitor International's Malaysia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government


Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment  
GBI Research, April 2011, Pages: 130
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence


New Zealand Pharmaceuticals and Healthcare Report Q4 2011  
Business Monitor International, Aug 2011, Pages: 330
Business Monitor International's New Zealand Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government


Neurostimulation - Global Strategic Business Report  
Global Industry Analysts, Inc., Sep 2010, Pages: 185
with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying NEUROSTIMULATION A GLOBAL STRATEGIC BUSINESS REPORT


Australia Pharmaceuticals and Healthcare Report Q3 2010  
Business Monitor International, May 2010, Pages: 90
Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies


Russia Pharmaceuticals and Healthcare Report Q1 2012  
Business Monitor International, Jan 2012, Pages: 93
intelligence on Poland's pharmaceuticals and healthcare industry. Executive Summary Russia Pharmaceuticals And Healthcare Industry SWOT Russia Political SWOT Russia Economic SWOT Russia Business Environment


Pakistan Pharmaceuticals and Healthcare Report Q1 2012  
Business Monitor International, Nov 2011, Pages: 98
Business Monitor International's Pakistan Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government


Results:  First -   Prev -   1 -   2 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds